Adverse event reporting
Executive Summary
FDA is extending the deadline for use of the new standardized adverse event reporting form until a final rule is issued amending current regulations, agency announces in Dec. 3 Federal Register. According to the original timetable, drug manufacturers would have begun using the new form on Nov. 30. FDA encourages use of the new form immediately, the notice states.